The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Bioactive Polymers for Wound Healing Applications. VitroGroR is a growth factor complex which enhances cell growth and migration, and hence has great potential for treating wounds. Tissue Therapies, which holds the rights to commercialization of VitroGroR, is seeking to develop methods of delivering VitroGroR in its active form to the wound environment. Two solutions to this problem will be developed in this project; a bioactive bandage containing a novel combination of microspheres and a hydrog ....Bioactive Polymers for Wound Healing Applications. VitroGroR is a growth factor complex which enhances cell growth and migration, and hence has great potential for treating wounds. Tissue Therapies, which holds the rights to commercialization of VitroGroR, is seeking to develop methods of delivering VitroGroR in its active form to the wound environment. Two solutions to this problem will be developed in this project; a bioactive bandage containing a novel combination of microspheres and a hydrogel matrix, and secondly an in-situ polymerisable matrix for treatment of deep wounds. The growth factor complex will be protected from aggressive proteases through encapsulation within microspheres, and the use of MMP-inhibiting comonomers.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668506
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
A Multi-Axis Biomaterials Testing Facility. Damage to bones and joints, due to injury or diseases such as osteoporosis and arthritis, is a major cause of disability and cost to the nation. Australia's ageing population contributes not only to an increasing incidence of such conditions, but also to more patients out-living implants such as replacement joints. In 2001-2, Australia spent over $800 million on joint replacement. Because over 11% of procedures are revisions of failed implants, even sm ....A Multi-Axis Biomaterials Testing Facility. Damage to bones and joints, due to injury or diseases such as osteoporosis and arthritis, is a major cause of disability and cost to the nation. Australia's ageing population contributes not only to an increasing incidence of such conditions, but also to more patients out-living implants such as replacement joints. In 2001-2, Australia spent over $800 million on joint replacement. Because over 11% of procedures are revisions of failed implants, even small improvements in implant life represent significant cost savings. By accurately simulating conditions within the body, this biomechanical testing facility will lead to new developments in implant designs and materials, in turn improving quality of life, productivity and treatment costs.Read moreRead less
An Integrated Biotechnological Process for Production of Lactic Acid from Carbohydrate-Waste Streams by Rhizopus sp. Lactic acid is the most widely occurring multifunctional organic acid. It has enormous applications in food and food-related industries, and great potential use for production of biodegradable and biocompatible polylactate polymers. The aim of this research is to develop an innovative biotechnological process, incorporating simultaneous saccharification and fermentation, which int ....An Integrated Biotechnological Process for Production of Lactic Acid from Carbohydrate-Waste Streams by Rhizopus sp. Lactic acid is the most widely occurring multifunctional organic acid. It has enormous applications in food and food-related industries, and great potential use for production of biodegradable and biocompatible polylactate polymers. The aim of this research is to develop an innovative biotechnological process, incorporating simultaneous saccharification and fermentation, which integrates the production of lactic acid with the treatment of high strength food industry ?effluent? streams - carbohydrate waste streams. The proposed SSF process will cultivate an identified fungal Rhizopus sp strain on the waste streams, as production substrates, leading to an environmentally friendly and economically sustainable new technology for the food industry.Read moreRead less
Molecularly engineered cell-instructive hydrogels for enhanced tissue regeneration. The outcomes of this project will be relevant to range of wounds, including burns, bed-sores, and diabetic and venous ulcers. Clearly, innovation in wound healing is urgently required as the treatment of wounds represents a significant challenge at all levels of our society, in terms of cost (physical, emotional and financial) to patients, the economy and to the wider community. Despite this obvious and overwhelm ....Molecularly engineered cell-instructive hydrogels for enhanced tissue regeneration. The outcomes of this project will be relevant to range of wounds, including burns, bed-sores, and diabetic and venous ulcers. Clearly, innovation in wound healing is urgently required as the treatment of wounds represents a significant challenge at all levels of our society, in terms of cost (physical, emotional and financial) to patients, the economy and to the wider community. Despite this obvious and overwhelming need, research in wound healing is relatively under-developed and has yet to adopt modern biotechnology and biomaterials approaches. This project is therefore directed at generating cost-effective frontier wound dressing technologies that accelerate wound repair.Read moreRead less
Special Research Initiatives - Grant ID: SR0354797
Funder
Australian Research Council
Funding Amount
$20,000.00
Summary
The Australian Tissue Engineering Network. Driven by four key nodes across the country, the Initiative aims to bring together geographically and financially separated groups into a critical mass of cell and tissue engineering research. This new and rapidly-growing field uses a bio-synthetic approach to replace, repair or regenerate damaged tissues and organs. The Initiative will build the framework which will enable the Network to: identify appropriate expertise, manage duplication, enhance co ....The Australian Tissue Engineering Network. Driven by four key nodes across the country, the Initiative aims to bring together geographically and financially separated groups into a critical mass of cell and tissue engineering research. This new and rapidly-growing field uses a bio-synthetic approach to replace, repair or regenerate damaged tissues and organs. The Initiative will build the framework which will enable the Network to: identify appropriate expertise, manage duplication, enhance communication, bring together innovative skill sets, create linkages, generate focussed research programs and foster novel commercial opportunities. Ultimately the Initiative and Network will deliver an improved quality of life, reduced healthcare costs, and increased productivity to Australia.Read moreRead less
Intelligent scaffolds and methods for repair of osteochondral defects. Osteoarthritis (OA) produces articulation of bone against bone resulting in extreme pain and disability. Of all musculoskeletal disorders, osteoarthritis has the greatest social and economic implications worldwide. By 2030, it is projected that 9.3% of the adult population will suffer from arthritis, significantly affecting their quality of life and overall productivity. A tissue engineered product capable of repairing osteoc ....Intelligent scaffolds and methods for repair of osteochondral defects. Osteoarthritis (OA) produces articulation of bone against bone resulting in extreme pain and disability. Of all musculoskeletal disorders, osteoarthritis has the greatest social and economic implications worldwide. By 2030, it is projected that 9.3% of the adult population will suffer from arthritis, significantly affecting their quality of life and overall productivity. A tissue engineered product capable of repairing osteochondral defects that does not require revision over time but becomes fully integrated with the host tissue will have significant benefits. It will improve patient activity and quality of life, and significantly reduce current health care costs associated with osteoarthritis sufferers.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE180100200
Funder
Australian Research Council
Funding Amount
$270,427.00
Summary
AutoStem: a high performance, automated stem cell bioengineering facility. This project aims to establish an automated stem cell bioengineering ("AutoStem") facility that will enable critical insights into the molecular mechanisms that underly the loss in stem cell function and tissue homeostasis as we age. The AutoStem facility expects to lead to the discovery of the key drivers of stem cell ageing and the development of novel technological solutions to maintain tissue function with age. The o ....AutoStem: a high performance, automated stem cell bioengineering facility. This project aims to establish an automated stem cell bioengineering ("AutoStem") facility that will enable critical insights into the molecular mechanisms that underly the loss in stem cell function and tissue homeostasis as we age. The AutoStem facility expects to lead to the discovery of the key drivers of stem cell ageing and the development of novel technological solutions to maintain tissue function with age. The outcomes produced from the AutoStem facility will have significant economic and social benefits in enabling healthy ageing and increased productivity for an ageing Australia.Read moreRead less
Scalable, high throughput microfluidic platforms for tissue specific biomaterials development and tissue genesis. The co-development of novel biomaterial platforms and new generation production methods for tissue analogues will provide the necessary stimulus for improved and more relevant methods of enhanced repair or regeneration of diseased or damaged tissues. These outcomes will result in faster time-to-market new generation therapeutic products for Australia and the world. These advances wil ....Scalable, high throughput microfluidic platforms for tissue specific biomaterials development and tissue genesis. The co-development of novel biomaterial platforms and new generation production methods for tissue analogues will provide the necessary stimulus for improved and more relevant methods of enhanced repair or regeneration of diseased or damaged tissues. These outcomes will result in faster time-to-market new generation therapeutic products for Australia and the world. These advances will have a significant impact on our healthcare costs and the quality of life for all Australians.Read moreRead less
Stem cell-based interface tissue engineering. Osteoarthritis (OA) causes extreme pain, disability, and reduced quality of life and overall productivity. It is the musculoskeletal disorder with the greatest social and economic implications internationally, with 9.3% of the adult population projected to suffer from OA by 2030. A tissue engineered product capable of functional repair of ligament-cartilage-bone tissue interfaces will have significant benefits. It will improve patient activity and qu ....Stem cell-based interface tissue engineering. Osteoarthritis (OA) causes extreme pain, disability, and reduced quality of life and overall productivity. It is the musculoskeletal disorder with the greatest social and economic implications internationally, with 9.3% of the adult population projected to suffer from OA by 2030. A tissue engineered product capable of functional repair of ligament-cartilage-bone tissue interfaces will have significant benefits. It will improve patient activity and quality of life, and significantly reduce OA-associated health care costs. This proposal will train a total of 12 new generation researchers in the emergent fields of stem cell biology and tissue engineering, having important benefits for the Australian scientific and industrial communities.Read moreRead less
Development and validation of virtual epithelial cancer models using an integrated modelling and experimental three-dimensional approach. The mathematical and experimental modelling of the human prostate and ovary applying quantitative bioengineering concepts will lead to virtual cancer models. This project aims to validate these multi-scale models to delineate biological and pathological avenues in healthy and disease tissue and improve prevention and treatment of prostate and ovarian cancer.